Essange Reagents

What Essange Reagents does

Essange Reagents is a Netherlands-based, privately held specialty diagnostics company that develops and distributes in-vitro diagnostic (IVD) reagents for blood grouping, immunology, and hematology, alongside ELISA kits, monoclonal and anti-idiotype antibodies, and Monocyte Activation Test (MAT) products for pyrogen testing. Its portfolio spans three pillars: (1) red cell and platelet serology, including the Cellbind and PeliControl reagent lines, the Magister C24 automated blood group analyzer, and the MASPAT solid-phase microwell assay for platelet antibody detection; (2) clinical and research immunology reagents such as the PeliKine Compact Cytokine ELISA kit, the IMMAGE Plus kit CE IVD, and CD monoclonal antibodies; and (3) MAT pyrogen testing services comprising validated PBMCs, culture medium supplement, and cytokine ELISAs.

The company monetizes through one-time sales of diagnostic reagents and kits to clinical laboratories, licensing/OEM supply of bulk reagents and custom assays to diagnostic and biotech companies, and pyrogen testing services delivered in conjunction with Sanquin Diagnostic Services B.V. Pricing is not publicly disclosed and orders are placed via email. Go-to-market relies on a global distributor network spanning more than 35 countries, supplemented by direct OEM sales and an events-calendar-driven field-marketing motion. The firm's core strategic asset is its partnership with Sanquin, the Dutch blood bank organization, which provides clinical validation infrastructure and immunohaematology expertise; the company is led by CEO Klaus Gogelein and CXO/CFO Linda Burger, employs 51-100 people, and operates from Amsterdam.

The company was founded in 2023 and is therefore early in its commercial trajectory. Its near-term strategic priorities appear to be expanding the distributor footprint, scaling Magister C24 placements into mid-volume labs, and converting MAT validation work into recurring pharmaceutical/biotech testing revenue. Revenue, funding history, and customer-level concentration are not disclosed in the available data.

Name

Essange Reagents

Legal name

Essange Reagents

Website

https://essange-reagents.nl

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

51–100 employees

Short description

Essange Reagents is a Netherlands-based specialty diagnostics company developing IVD reagents for blood grouping, immunology, and pyrogen testing, plus the Magister C24 automated blood group analyzer, serving clinical laboratories and biotech OEM customers in 35+ countries via a distributor network and Sanquin partnership.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

Keywords

• Blood grouping reagents
• Immune reagents
• Clinical immunology diagnostics
• Pyrogen testing
• ELISA diagnostic kits

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Reagent Sales: Sale of blood grouping reagents, immune reagents, and diagnostic kits to clinical laboratories and healthcare facilities.
2. OEM Reagents and Assays: Bulk reagent supply and assay development services to diagnostic and biotech companies for OEM use.
3. Pyrogen Testing Services: MAT products and services including validated PBMCs, culture medium supplement, and cytokine ELISAs, with Sanquin Diagnostic Services performing pre-validation and batch release testing.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Essange Reagents develops and supplies in vitro diagnostic (IVD) reagents for blood grouping, clinical and research immunology, and pyrogen testing. The portfolio includes the Magister C24 automated blood group analyzer, MASPAT platelet antibody detection assays, red cell serology reagents (Cellbind, PeliControl), ELISA kits, monoclonal antibodies, and Monocyte Activation Test (MAT) products for pyrogen testing. Products are CE IVD certified and distributed to diagnostic laboratories, biotech companies, and pharmaceutical manufacturers through a network spanning 35+ countries, with a strategic operational partnership with Sanquin for MAT development and batch release testing.

Product overview

Essange Reagents is a specialized diagnostics company that develops and delivers high-quality blood grouping and immune reagents. The company operates as a product portfolio rather than a unified platform, organized across three main areas: (1) Blood grouping products including Cellbind, Magister C24, MASPAT, and PeliControl for red cell serology diagnostics; (2) Immune reagents including anti-idiotype antibodies, PeliKine Compact Cytokine ELISA kits, IMMAGE Plus kit CE IVD, and monoclonal antibodies for clinical and research immunology; and (3) Pyrogen testing services using the Monocyte Activation Test (MAT) with validated PBMCs, culture medium supplements, and cytokine ELISA kits. The company also offers OEM reagents and assays for diagnostic and biotech companies.

Differentiator

Problem solved

Functional benefit

Brands

• Magister C24: A compact and fully automated blood group analyser, the first fully automated blood group analyser specifically designed for laboratories with a need for flexible and automated blood group analysis.
• MASPAT
• Cellbind
• PeliControl

Products and services

• Cellbind

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• SanquincoreStrategic or Co-development PartnerEssange Reagents operates in partnership with Sanquin, combining expertise in immunohaematology and diagnostic reagent development. Sanquin Diagnostic Services B.V. performs product pre-validation and routine batch release testing for MAT pyrogen testing services. The partnership leverages Sanquin's expertise as a leading blood bank organization to support development, production, and support for Monocyte Activation Testing (MAT).

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Immucor (Werfen): Immucor (part of the Werfen group) specializes in transfusion and transplantation diagnostics, including the Echo and NEO blood bank analyzers and a broad reagent menu, making it one of the closest direct competitors to Essange in serology reagents and platelet antibody testing.
• Bio-Rad Laboratories: Bio-Rad is one of the largest global suppliers of blood typing reagents, serology controls, and automated blood bank instruments (e.g., IH-1000). It competes head-on with Essange across routine red cell serology, ELISA reagents, and immunohematology platforms, serving the same clinical blood bank and reference laboratory customers.
• QuidelOrtho (formerly Ortho Clinical Diagnostics): QuidelOrtho's Ortho Diagnostics franchise is a leading global provider of immunohematology reagents and the Ortho Vision blood bank analyzer, directly competing with Essange's Cellbind, PeliControl, and Magister C24 product lines in blood typing and crossmatching.
• Grifols: Grifols' Diagnostic division supplies blood typing reagents, serology products, and immunohematology instruments through brands such as Progenika and through its donor screening business, overlapping directly with Essange's blood grouping reagent portfolio and customer base.

Others

• Sanquin: Sanquin is the Dutch national blood bank organization and Essange's strategic co-development partner; it provides domain expertise, validated PBMCs, and Diagnostic Services B.V. for MAT pre-validation and batch release, making it a critical ecosystem participant rather than a direct competitor.

Broad incumbents

• Thermo Fisher Scientific: Through its Life Sciences and ImmunoDiagnostics businesses, Thermo Fisher manufactures ELISA kits, cytokine reagents, and OEM bulk biomaterials that compete with Essange's PeliKine Compact Cytokine ELISA, IMMAGE Plus, and OEM reagents offerings to clinical and research immunology customers.
• Merck KGaA (Sigma-Aldrich): Merck's Life Science business supplies antibodies, ELISA kits, and OEM raw materials to clinical immunology and biotech customers, overlapping with Essange's anti-idiotype antibodies, monoclonal antibodies, and OEM reagent business.

Emerging players

• Hycor Biomedical: Hycor Biomedical develops in-vitro allergy and immunology diagnostics including IgE assays and ELISA-based platforms, providing an adjacent emerging competitor profile to Essange's clinical immunology product line.
• Fapon Biotech: Fapon Biotech is a China-based IVD raw materials and finished reagent manufacturer focused on OEM supply and bulk reagents to diagnostics OEMs globally, making it a comparable emerging player in the same bulk-reagent OEM space that Essange targets.
• BioLegend (Revvity): BioLegend, now part of Revvity, is a leading supplier of immunology reagents including ELISA kits, cytokine panels, and monoclonal antibodies, making it a relevant emerging competitor in the clinical and research immunology reagent segment where Essange competes with PeliKine and CD monoclonal antibodies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/essangereagents

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Essange Reagents